ClinicalTrials.Veeva

Menu

Influence of Preprandial Metformin Administration on Carbohydrate Absorption (METTIME)

U

University Hospital, Lille

Status

Not yet enrolling

Conditions

Impaired Glucose Tolerance
Type2 Diabetes

Treatments

Other: Oral glucose tolerance test (OGTT) with or without metformin

Study type

Interventional

Funder types

Other

Identifiers

NCT04018105
2018_35
2019-001175-36 (EudraCT Number)

Details and patient eligibility

About

Type 2 diabetes is spreading worldwide as well as obesity. Metformin is the most prescribed antidiabetic medication. One suggested mechanism of action is by decreasing carbohydrate absorption.

It is usually recommended to take metformin during the meal to decrease gastrointestinal side effects. However, if metformin decreases carbohydrate absorption, this might not be the most efficient intake.

To study the influence of preprandial metformin administration on carbohydrate absorption, it will repeat 3 oral glucose tolerance test on obese dysglycemic patients, without metformin or with metformin administer 30 or 60 minutes before. We will also evaluate how it impacts gastrointestinal tolerance.

Enrollment

24 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obesity (BMI ≥30 kg/m2)
  • Dysglycemia (HbA1c≥ 6,0 %)
  • No anti diabetic medication

Exclusion criteria

  • No obesity (BMI < 30 kg/m2)
  • No dysglycemia (HbA1c <6,0%)
  • Treatment that might interfere with carbohydrate absorption (anti diabetic medication, antibiotics, probiotics, steroids)
  • Anemia (Hb <12 g/dL)
  • Organ failure
  • Inflammatory Bowel Disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups, including a placebo group

taking metformin 30 or 60 minutes before the OGTT
Experimental group
Treatment:
Other: Oral glucose tolerance test (OGTT) with or without metformin
No metformin before OGTT
Placebo Comparator group
Treatment:
Other: Oral glucose tolerance test (OGTT) with or without metformin

Trial contacts and locations

0

Loading...

Central trial contact

Camille Marciniak, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems